Altitude Lab, the platform-first biotech-startup accelerator founded by Recursion (NASDAQ: RXRX), announced today that its portfolio companies have collectively raised more than $205 million in ...

Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The letter emphasizes a long-term, ...

Twin Cities-based ProEncia Biotechnology, a biopharma startup, today announced the company has closed significant pre-seed funding to advance its next-generation periodontal disease treatment. Funding ...

This initial tranche of funding was sourced from both individual and institutional investors. CapeHaven is focused on identifying high ...

To be sure, Danaher is not actually a biotech company. It sells tools, instruments, and services used by biotech and pharma companies to develop and manufacture drugs. It's essentially a ...

CREATE Medicines has a new name, an expanded pipeline, and now fresh funding to propel the company’s first CAR-T candidates ...

The BIO campaign warns that decreased funding could hamper both current patient care and the future pipeline of medical breakthroughs. By featuring documentary-style stories of researchers and ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

When chip giant Nvidia (NVDA) shows interest in any company, analysts and investors take note. According to Nvidia’s most ...

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

A Boston biotechnology company that abandoned plans to go public last year completed a successful initial public offering ...